文献速递骨肌技术与安全US

基于超声的人工智能模型预测软组织肿瘤Ki-67增殖指数

Ultrasound-based artificial intelligence model for prediction of Ki-67 proliferation index in soft tissue tumors.
PubMed 文献 · Acad Radiol · 2024-10-15

本回顾性研究纳入两家医院共394例软组织肿瘤患者,以医院1为训练队列(323例,高/低Ki-67分别为89/234例)、医院2为外部验证队列(71例,高/低Ki-67分别为23/48例),构建融合临床、影像组学和深度学习特征的超声模型预测Ki-67表达水平;基于临床、影像组学和深度学习的三特征融合模型表现最佳,训练队列AUC为0.911(95%CI 0.886-0.935),验证队列AUC为0.923(95%CI 0.873-0.972),校准良好且具有临床实用性。

要点

  • 超声融合临床、影像组学和深度学习特征的三特征融合模型预测软组织肿瘤Ki-67表达水平表现最佳。
  • 该模型训练队列AUC为0.911(95%CI 0.886-0.935),外部验证队列AUC为0.923(95%CI 0.873-0.972)。
  • 验证集上基于临床、影像组学和深度学习的决策融合模型诊断性能显著差于三种特征融合模型。

核心结论

  • 基于超声的临床、影像组学和深度学习特征融合模型在预测软组织肿瘤Ki-67表达水平方面表现出良好性能。

研究设计与样本

  • 回顾性研究,共纳入2021年1月至2023年12月两家医院394例软组织肿瘤患者,医院1为训练队列(323例,高/低Ki-67分别为89/234例),医院2为外部验证队列(71例,高/低Ki-67分别为23/48例)。

关键影像表现/征象

  • 评估的临床和超声特征包括年龄、性别、肿瘤大小、形态、边缘、内部回声和血流。
  • 采用单因素和多因素logistic回归分析筛选具有显著相关性的危险因素。

诊断标准与关键数值

  • 提取影像组学和深度学习特征后,采用支持向量机构建特征融合模型。
  • 将临床特征、影像组学特征和深度学习特征分别获得的预测结果组合,构建决策融合模型。
  • 基于临床、影像组学和深度学习的三特征融合模型训练队列AUC为0.911(95%CI 0.886-0.935),验证队列AUC为0.923(95%CI 0.873-0.972)。
  • DeLong检验显示,验证集上基于临床、影像组学和深度学习的决策融合模型诊断性能显著差于三种特征融合模型。
  • 其他模型之间诊断性能无统计学差异。

临床应用与阅片要点

  • 作者结论认为,基于超声的临床、影像组学和深度学习特征融合模型在预测软组织肿瘤Ki-67表达水平方面表现出良好性能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To investigate the value of deep learning (DL) combined with radiomics and clinical and imaging features in predicting the Ki-67 proliferation index of soft tissue tumors (STTs).

MATERIALS AND METHODS: In this retrospective study, a total of 394 patients with STTs admitted from January 2021 to December 2023 in two separate hospitals were collected. Hospital-1 was the training cohort (323 cases, of which 89 and 234 were high and low Ki-67, respectively) and Hospital-2 was the external validation cohort (71 cases, of which 23 and 48 were high and low Ki-67, respectively). Clinical and ultrasound characteristics including age, sex, tumor size, morphology, margins, internal echoes and blood flow were assessed. Risk factors with significant correlations were screened by univariate and multivariate logistic regression analyses. After extracting the radiomics and DL features, the feature fusion model is constructed by Support Vector Machine. The prediction results obtained from separate clinical features, radiomics features and DL features were combined to construct decision fusion models. Finally, the DeLong test was used to compare whether the AUCs between the models were significantly different.

RESULTS: The three feature fusion models and three decision fusion models constructed demonstrated excellent diagnostic performance in predicting Ki-67 expression levels in STTs. Among them, the feature fusion model based on clinical, radiomics, and DL performed the best with an AUC of 0.911 (95% CI: 0.886-0.935) in the training cohort and 0.923 (95% CI: 0.873-0.972) in the validation cohort, and proved to be well-calibrated and clinically useful. The DeLong test showed that the decision fusion models based on clinical, radiomics and DL performed significantly worse than the three feature fusion models on the validation set. There was no statistical difference in diagnostic performance between the other models.

CONCLUSION: The ultrasound-based fusion model of clinical, radiomics, and DL features showed good performance in predicting Ki-67 expression levels in STTs.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Dai X, Lu H, Wang X, et al. Ultrasound-based artificial intelligence model for prediction of Ki-67 proliferation index in soft tissue tumors. Acad Radiol. 2024. PMID: 39406581. doi:10.1016/j.acra.2024.09.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。